Newsfiscal.ai
MetaVia Announces Positive Interim Phase 1 Data for DA-1726
· Published
Article summary
MetaVia reported positive interim results from Part 3B of its Phase 1 clinical trial for DA-1726, showing significant reductions in body weight and liver fat.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…